UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000050801 |
|---|---|
| Receipt number | R000057890 |
| Scientific Title | A survey of online support for cancer patients |
| Date of disclosure of the study information | 2023/05/01 |
| Last modified on | 2023/04/10 14:41:46 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
A survey of online support for cancer patients
Acronym
Online cancer support
Scientific Title
A survey of online support for cancer patients
Scientific Title:Acronym
Online cancer support
Region
| Japan |
Condition
Condition
cancer
Classification by specialty
| Medicine in general | Hematology and clinical oncology |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
To investigate sufferings and troubles of cancer patients using online cancer support application.
Basic objectives2
Others
Basic objectives -Others
Qualitative and quantitative survey
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Proportion, characteristics, managements, and outcomes of problems in cancer patients
Key secondary outcomes
Time from the start to the end of online support
Time from the start of online support to face-to-face support
Types of professions in online support team in Hamamatsu Univ. Hospital
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Cancer patients and/or families.
Key exclusion criteria
Subjects who do not consent to the survey.
Target sample size
300
Research contact person
Name of lead principal investigator
| 1st name | Hiroya |
| Middle name | |
| Last name | Takeuchi |
Organization
Hamamatsu University School of Medicine
Division name
Cancer Center
Zip code
4313192
Address
Handayama 1-20-1, Hamamatsu
TEL
053-435-2111
takeuchi@hama-med.ac.jp
Public contact
Name of contact person
| 1st name | Masato |
| Middle name | |
| Last name | Karayama |
Organization
Hamamatsu University School of Medicine
Division name
Cancer Center
Zip code
431-3192
Address
Handayama 1-20-1, Hamamatsu
TEL
053-435-2111
Homepage URL
karayama@hama-med.ac.jp
Sponsor or person
Institute
Hamamatsu University School of Medicine
Institute
Department
Personal name
Funding Source
Organization
Hamamatsu University School of Medicine
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
The institutional review board of Hamamatsu University School of Medicine
Address
Handayama 1-20-1, Hamamatsu
Tel
053-435-2680
rinri@hama-med.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2023 | Year | 05 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2023 | Year | 03 | Month | 16 | Day |
Date of IRB
| 2023 | Year | 04 | Month | 10 | Day |
Anticipated trial start date
| 2023 | Year | 05 | Month | 01 | Day |
Last follow-up date
| 2028 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Data collection
Characteristics: age, sex, patients or families, types of cancer, stages, reasons of detection of cancer, date of diagnosis of cancer, name of hospital, name of treatment department, content of current treatment for cancer, concomitant diseases
Content of problems: qualitative description
Contents of supports: types of professions that respond each problem, contents of supports, time from the start to the end of online support, time from the start of the online support to face-to face support.
Questionnaire for the online support.
Management information
Registered date
| 2023 | Year | 04 | Month | 10 | Day |
Last modified on
| 2023 | Year | 04 | Month | 10 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000057890
